FI901761A0 - Menetelmä lääkeaineina käyttökelpoisten pyridiinijohdannaisten valmistamiseksi - Google Patents

Menetelmä lääkeaineina käyttökelpoisten pyridiinijohdannaisten valmistamiseksi

Info

Publication number
FI901761A0
FI901761A0 FI901761A FI901761A FI901761A0 FI 901761 A0 FI901761 A0 FI 901761A0 FI 901761 A FI901761 A FI 901761A FI 901761 A FI901761 A FI 901761A FI 901761 A0 FI901761 A0 FI 901761A0
Authority
FI
Finland
Prior art keywords
pyridine derivatives
drug
preparation
derivatives useful
formula
Prior art date
Application number
FI901761A
Other languages
English (en)
Swedish (sv)
Other versions
FI95373C (fi
FI95373B (fi
Inventor
Ian Anthony Cliffe
Alan Chapman White
Howard Langham Mansell
Richard Simon Todd
Original Assignee
Wyeth John & Brother Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth John & Brother Ltd filed Critical Wyeth John & Brother Ltd
Publication of FI901761A0 publication Critical patent/FI901761A0/fi
Application granted granted Critical
Publication of FI95373B publication Critical patent/FI95373B/fi
Publication of FI95373C publication Critical patent/FI95373C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FI901761A 1989-04-07 1990-04-06 Menetelmä lääkeaineina käyttökelpoisten pyridiinijohdannaisten valmistamiseksi FI95373C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8907865 1989-04-07
GB898907865A GB8907865D0 (en) 1989-04-07 1989-04-07 Tetrahydroquinoline derivatives

Publications (3)

Publication Number Publication Date
FI901761A0 true FI901761A0 (fi) 1990-04-06
FI95373B FI95373B (fi) 1995-10-13
FI95373C FI95373C (fi) 1996-01-25

Family

ID=10654625

Family Applications (1)

Application Number Title Priority Date Filing Date
FI901761A FI95373C (fi) 1989-04-07 1990-04-06 Menetelmä lääkeaineina käyttökelpoisten pyridiinijohdannaisten valmistamiseksi

Country Status (22)

Country Link
US (1) US5075303A (fi)
EP (1) EP0395244B1 (fi)
JP (1) JP2945064B2 (fi)
KR (1) KR0156569B1 (fi)
AT (1) ATE149031T1 (fi)
AU (1) AU625845B2 (fi)
CA (1) CA2014062C (fi)
DD (1) DD298391A5 (fi)
DE (1) DE69029954T2 (fi)
DK (1) DK0395244T3 (fi)
ES (1) ES2099703T3 (fi)
FI (1) FI95373C (fi)
GB (2) GB8907865D0 (fi)
GR (1) GR3023396T3 (fi)
HK (1) HK121994A (fi)
HU (1) HU217128B (fi)
IE (1) IE63627B1 (fi)
IL (1) IL94011A (fi)
NZ (1) NZ233222A (fi)
PH (1) PH27590A (fi)
PT (1) PT93673B (fi)
ZA (1) ZA902662B (fi)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2660657B1 (fr) * 1990-04-09 1993-05-07 Adir Nouveaux derives du 3-aminochromane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
US5273994A (en) * 1990-04-09 1993-12-28 Adir Et Compagnie 3-aminochroman compounds
GB9019942D0 (en) * 1990-09-12 1990-10-24 Wyeth John & Brother Ltd Azetidine derivatives
US5532243A (en) * 1992-02-14 1996-07-02 The Dupont Merck Pharmaceutical Company Antipsychotic nitrogen-containing bicyclic compounds
GB9304632D0 (en) * 1993-03-06 1993-04-21 Wyeth John & Brother Ltd Amide derivatives
JPH09510695A (ja) * 1994-01-03 1997-10-28 エイシア・ファーマシュウティカルズ，インコーポレイテッド ８−アザ、６−アザ、および６，８−ジアザ−１，４−ジヒドロキノキサリン−２，３−ジオン類およびそのグリシン／ｎｍｄａリセプターに対するアンタゴニストとしての使用
US5609849A (en) * 1994-03-11 1997-03-11 The Trustees Of The University Of Pennsylvania Serotonin (5-HT1A) receptor ligands and imaging agents
US6180632B1 (en) * 1997-05-28 2001-01-30 Aventis Pharmaceuticals Products Inc. Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
US7105513B2 (en) * 2002-08-07 2006-09-12 Sanofi-Avertis Deutschland Gmbh Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals
US8426590B2 (en) * 2009-03-23 2013-04-23 Cipla Limited Process for the preparation of doxazosin and salts thereof
US9266840B2 (en) * 2011-10-18 2016-02-23 Astellas Pharma Inc. Bicyclic heterocyclic compound
EP3126451B1 (en) * 2014-04-01 2020-09-09 Howard Hughes Medical Institute Azetidine-substituted fluorescent compounds

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH566315A5 (fi) * 1972-04-04 1975-09-15 Ciba Geigy Ag
GB1463582A (en) * 1974-03-05 1977-02-02 Wyeth John & Brother Ltd Pyridine derivatives
GB1463583A (en) * 1974-03-05 1977-02-02 Wyeth John & Brother Ltd Halo and hydroxy compounds
DK309678A (da) * 1977-07-18 1979-01-19 Sandoz Ag Fremgangsmaade til fremstilling af tetralinderivater
SE8004002L (sv) * 1980-05-29 1981-11-30 Arvidsson Folke Lars Erik Terapeutiskt anvendbara tetralinderivat
DK111387A (da) * 1986-03-05 1987-09-06 Otsuka Pharma Co Ltd Carbostyrilderivater og salte deraf, laegemiddel indeholdende saadanne derivater samt fremgangsmaade til fremstilling af derivaterne
US4748182A (en) * 1986-03-05 1988-05-31 Merrell Dow Pharmaceuticals Inc. Aromatic 2-aminoalkyl-1,2-benzoisothiazol-3(2H)one-1,1-dioxide derivatives and their use as anti-hypertensive and anxiolytic agents
JPS63107990A (ja) * 1986-05-14 1988-05-12 Nippon Shinyaku Co Ltd キノリンカルボン酸誘導体
DE3718317A1 (de) * 1986-12-10 1988-06-16 Bayer Ag Substituierte basische 2-aminotetraline
DE3719924A1 (de) * 1986-12-22 1988-06-30 Bayer Ag 8-substituierte 2-aminotetraline
US4894084A (en) * 1987-12-29 1990-01-16 Fmc Corporation Substituted quinolinonyl and dihydroquinolinonyl triazolinone herbicides
US4878941A (en) * 1987-12-29 1989-11-07 Fmc Corporation Herbicides

Also Published As

Publication number Publication date
US5075303A (en) 1991-12-24
GB2230007B (en) 1992-10-14
GR3023396T3 (en) 1997-08-29
DE69029954D1 (de) 1997-03-27
JPH02290852A (ja) 1990-11-30
HK121994A (en) 1994-11-11
NZ233222A (en) 1991-07-26
KR0156569B1 (ko) 1998-11-16
ZA902662B (en) 1991-02-27
KR900016138A (ko) 1990-11-12
JP2945064B2 (ja) 1999-09-06
DE69029954T2 (de) 1997-05-28
HUT54658A (en) 1991-03-28
ATE149031T1 (de) 1997-03-15
IE63627B1 (en) 1995-05-17
AU5297190A (en) 1990-10-11
GB8907865D0 (en) 1989-05-24
EP0395244A1 (en) 1990-10-31
FI95373C (fi) 1996-01-25
DD298391A5 (de) 1992-02-20
IL94011A (en) 1994-06-24
PH27590A (en) 1993-08-18
HU217128B (hu) 1999-11-29
CA2014062C (en) 2000-06-13
GB2230007A (en) 1990-10-10
EP0395244B1 (en) 1997-02-19
DK0395244T3 (da) 1997-03-17
FI95373B (fi) 1995-10-13
HU902108D0 (en) 1990-08-28
PT93673B (pt) 1996-08-30
PT93673A (pt) 1990-11-20
CA2014062A1 (en) 1990-10-07
AU625845B2 (en) 1992-07-16
GB9007889D0 (en) 1990-06-06
ES2099703T3 (es) 1997-06-01

Similar Documents

Publication Publication Date Title
MA21778A1 (fr) Procede d'obtention de derives de n - ( 3-hydroxy-4 piperidinyl ) dihydro-benzofuranne, dihydro-2h- ,benzopyranne ou dihydro benzodioxin ) carboxamide .
FI891980A0 (fi) Menetelmä terapeuttisesti aktiivisten N1-(1,2-cis-2-halogeenisyklopropyyli)substituoitujen pyridonikarboksyylihappojohdannaisten valmistamiseksi
FI102175B (fi) Menetelmä terapeuttisesti käyttökelpoisten piperatsiinijohdannaisten v almistamiseksi
FI102609B1 (fi) Menetelmä valmistaa farmakologisesti arvokas substituoidun bentso[5,6]sykloheptapyridiinin pyridiini-N-oksidi
CS782686A2 (en) Method of benzimidazole derivatives production
FI901761A0 (fi) Menetelmä lääkeaineina käyttökelpoisten pyridiinijohdannaisten valmistamiseksi
DE3777735D1 (de) Imid-derivate, ihre herstellung und ihre verwendung.
HU911301D0 (en) Process for producing 2,9-disubstituted 4h-pyrido(1,2a)-pyrimidine derivatives and pharmaceutical preparatives containing these compounds as active substance
DE3882895D1 (de) Imid-derivate, ihre herstellung und verwendung.
ATE94535T1 (de) 4-amino-3-acylchinolin-derivate und ihre verwendung als inhibitoren der magensekretion.
NO930284D0 (no) Pyridinderivater, fremgangsmaate for deres fremstilling oganvendelse derav
DE69810340D1 (de) Naphtho-imidazo(1,2-a)pyridin derivate, deren herstellung und deren verwendung in der behandlung von störungen des zentralnervensystems
FI894125A0 (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisen 3-piperidinyyli-indatsolin valmistamiseksi

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed

Owner name: JOHN WYETH & BROTHER LIMITED